TurnerL., ChoplinF., DugardP., HermensJ., JaeckhR., MarsmannM., and RobertsD. (1987). Structure-activity relationships in toxicology and ecotoxicology: an assessment.Toxicology in Vitro1, 143–171.
3.
KarcherW. (1992). Basic concepts and aims of QSAR studies. In Quantitative Structure-Activity Relationships (QSAR) in Toxicology (ed. CocciniT., GiannoniL., KarcherW., ManzoL., RoiR.), pp. 5–25. Luxembourg: CEC.
4.
LivingstoneD.J. (1994). Computational techniques for the prediction of toxicity.Toxicology in Vitro8, 873–877.
5.
LeahyD.E., TaylorP.J., and WaitA.R. (1989). Model solvent systems for QSAR. I. Propylene glycol dipelargonate (PGDP). A new standard solvent for use in partition coefficient determination.Quantitative Structure-Activity Relationships8, 17–31.
6.
KönemannH. (1981). Quantitative structure-activity relationships in fish toxicity. I. Relationship for 50 industrial pollutants.Toxicology19, 209–221.
7.
JäckelH., and KleinW. (1991). Prediction of mammalian toxicity by quantitative structure-activity relationships: aliphatic amines and anilines.Quantitative Structure-Activity Relationships10, 198–204.
8.
DevillersJ. (1992). Statistical analyses in drug design and environmental chemistry: basic concepts. In Quantitative Structure-Activity Relationships (QSAR) in Toxicology (ed. CocciniT., GiannoniL., KarcherW., ManzoL., RoiR.), pp. 27–41. Luxembourg: CEC.
9.
BarrattM.D. (1995). Quantitative structure-activity relationships for skin corrosivity of organic acids, bases and phenols.Toxicology Letters75, 169–176.
10.
BarrattM.D. (1995). The role of structure-activity relationships and expert systems in alternative strategies for the determination of skin sensitisation, skin corrosivity and eye irritation.ATLA23, 111–122.
11.
HaggardH.W. (1924). The absorption, distribution and elimination of ethyl ether. II. Analysis of the mechanism of the absorption and elimination of such a gas or vapour as ethyl ether.Journal of Biological Chemistry59, 753–770.
12.
MaplesonW.W. (1963). Quantitative predictions of anaesthetic concentrations. In Uptake and Distribution of Anaesthetic Agents (ed. PapperE.M., KitzR.J.), pp. 104–119. New York: McGraw-Hill.
13.
RiggsD.S. (1963). The Mathematical Approach to Physiological Problems: A Critical Primer.Cambridge, MA, USA: MIT Press.
14.
Fiserova-BergerovaV., and HoladayD.A. (1979). Uptake and clearance of inhalation anaesthetics in man.Drug Metabolism Reviews9, 43–60.
15.
TeorellT. (1937). Kinetics of distribution of substances administered to the body. I. The extra-vascular modes of administration.Archives of Internal Pharmacodynamics57, 205–240.
16.
BischoffK.B., DedrickR.L., ZaharkoD.S., and LongstrethJ.A. (1971). Methotrexate pharmacokinetics.Journal of Pharmaceutical Science60, 1128–1133.
17.
DedrickR.L. (1973). Animal scale up.Journal of Pharmacokinetics and Biopharmacy1, 435–461.
RamseyJ.R., and AndersenM.E. (1984). A physiologically based description of the inhalation pharmacokinetics of styrene in rats and humans.Toxicology and Applied Pharmacology73, 159–175.
20.
SatoxA., SatoY., & HirosawaK. (1971). Solubility of benzene, toluene and m-xylene in blood.Japanese Journal of Industrial Health14, 3–8.
21.
DedrickR.L., ForresterD.D., and HoD.H.O. (1971). In vitro–in vivo correlation of drug metabolism: deamination of 1-β-D-arabinofuranosyl-cytosine.Biochemical Pharmacology21, 1–16.
22.
GreenT., ProvanW.M., DugardP.H., and CookS.K. (1988). Methylene Chloride (Dichloromethane): Human Risk Assessment Using Experimental Animal Data. ECETOC Technical Report No. 32, 64 pp. Brussels: ECETOC.
23.
JollesG., and CordierA. eds (1992). In Vitro Methods in Toxicology, 607 pp. London: Academic Press.
24.
WatsonR.R. ed. (1992). In Vitro Methods of Toxicology, 298 pp. Boca Raton, FL, USA: CRC Press.
25.
FrazierJ.M. ed. (1992). In Vitro Toxicity Testing: Applications to Safety Evaluation, 299 pp. New York: Marcel Dekker.
26.
GadS.C. (1993). Alternatives to in vivo studies in toxicology. In General and Applied Toxicology, Vol. 1 (ed. BallantyneB., MarrsT., TurnerP.), pp. 179–206. Basingstoke, Hants., UK: Macmillan.
27.
FryJ.R. (1993). Development in in vitro toxicology.Comparative Haematology International3, 4–7.
28.
RoberfroidM. (1994). Alternatives in safety testing: progress or uselessness?ATLA22, 438–444.
29.
FentemJ.H. (1994). The use of human tissues in in vitro toxicology, Stirling, 28/29 April 1993. Summary of general discussions.Human and Experimental Toxicology13, 445–449.
30.
WilcoxD.K., and BrunerL.H. (1990). In vitro alternatives for ocular safety testing: an outline of assays and possible future developments.ATLA18, 117–128.
31.
DeLeoV.A. (1992). Cutaneous irritancy. In In Vitro Toxicity Testing: Applications to Safety Evaluation, (ed. FrazierJ.M.), pp. 191–203. New York: Marcel Dekker.
32.
BlaauboerB.J., BoobisA.R., CastellJ.V., CoeckeS., GroothuisG.M.M., GuillouzoA., HallT.J., HawksworthG.M., LorenzonG., MiltenburgerH.G., RogiersV., SkettP., VillaP., and WiebelF.J. (1994). The practical applicability of hepatocyte cultures in routine testing. The report and recommendations of ECVAM workshop 1.ATLA22, 231–241.
33.
HawksworthG.M., BachP.H., DekantW., DieziJ.E., HarpurE., LockE.A., MacDonaldC., MorinJ-P., NagelkerkeJ.F., PfallerW., RuttenA. A.J.J.L., RyanM.P., ToutainH.J., and TrevisanA. (1995). Nephrotoxicity testing in vitro. The report and recommendations of an ECVAM workshop.ATLA, in press.
34.
AtterwillC.K., BruininkA., DrejerJ., DuarteE., McFarlane AbdullaE., MeredithC., NicoteraP., ReganC., Rodríguez-FarréE., SimpsonM.G., SmithR., VeronesiB., VijverbergH., WalumE., and WilliamsD.C. (1994). In vitro neurotoxicity testing. The report and recommendations of ECVAM workshop 3.ATLA22, 350–362.
35.
GarleM.J., FentemJ.H., and FryJ.R. (1994). In vitro cytotoxicity tests for the prediction of acute toxicity.Toxicology in Vitro8, 1303–1312.
36.
BallsM., and FentemJ.H. (1992). The use of basal cytotoxicity and target organ toxicity tests in hazard identification and risk assessment.ATLA20, 368–388.
37.
BasketterD.A., WhittleE., and ChamberlainM. (1994). Identification of irritation and corrosion hazards to skin: an alternative strategy to animal testing.Food and Chemical Toxicology32, 539–542.
38.
SpielmannH., LovellW.W., HölzleE., JohnsonB.E., MaurerT., MirandaM.A., PapeW.J.W., SaporaO., and SladowskiD. (1994). In vitro phototoxicity testing. The report and recommendations of ECVAM workshop 2.ATLA22, 314–348.
39.
BasketterD.A., ScholesE.W., ChamberlainM., and BarrattM.D. (1995). An alternative strategy to the use of guinea-pigs for the identification of skin sensitisation hazard.Food and Chemical Toxicology, in press.
40.
HanschC., MaloneyP.P., FujitaT., and MuirR.M. (1962). Correlation of biological activity of phenoxyacetic acids with Hammett substituent constants and partition coefficients.Nature194, 178–180.
41.
van LeeuwenC.J., van der ZandtP.T.J., AldenbergT., VerhaarH.J.M., and HermensJ.L.M. (1992). Application of quantitative structure-activity relationships, extrapolation and equilibrium partitioning in aquatic effects assessment. I. Narcotic industrial pollutants.Environmental Toxicology and Chemistry11, 267–282.
42.
HanschC., and ClaytonJ.M. (1973). Lipophilic character and biological activity of drugs. II. The parabolic case.Journal of Pharmaceutical Science62, 1–21.
43.
Crura BrownA., and FrazerT. (1868/9). On the connection between chemical constitution and physiological action. I. On the physiological action of the salts of the ammonia bases derived from Strychnia, Brucia, Thebaia, Codeia, Morphia, and Nicotia.Transactions of the Royal Society of Edinburgh25, 151–203.
44.
HydeR.M., and LivingstoneD.J. (1988). Perspectives in QSAR: computer chemistry and pattern recognition.Journal of Computer-Aided Molecular Design2, 145–157.
45.
LivingstoneD.J., HudsonB.D., GeorgeA., and FordM.G. (1991). The use of molecular dynamics in QSAR studies. In QSAR: Rational Approaches to the Design of Bioactive Compounds (ed. SilipoC., VittoriaA.), pp. 557–560. Amsterdam: Elsevier.
46.
LivingstoneD.J. The trouble with chemometrics …? (1995). In Proceedings of the 10th European Symposium on QSAR, (ed. SanzF.) Barcelona: J.R. Prous, in press.
47.
LivingstoneD.J. (1991). Pattern recognition methods in rational drug design. In Molecular Design and Modelling: Concepts and Applications. Part B. Methods in Enzymology, Volume 203 (ed. LangoneJ.J.), pp. 613–638. San Diego, USA: Academic Press.
48.
RidingsJ.E., ManallackD.T., SaundersM.R., BaldwinJ.A., and LivingstoneD.J. (1992). Multivariate quantitative structure-toxicity relationships in a series of dopamine mimetics.Toxicology76, 209–217.
49.
BarrattM.D. (1995). A quantitative structure-activity relationship for the eye irritation potential of neutral organic chemicals.Toxicology Letters, in press.
50.
ChamberlainM., and BarrattM.D. (1995). Practical applications of QSAR to in vitro toxicology by consideration of eye irritation.Toxicology in Vitro, in press.
51.
SpielmannH., GernerI., KalweitS., MoogR., WirnsbergerT., KrauserK., KreilingR., KreuzerH., LüpkeN.P., MiltenburgerH.G., MüllerN., MürmannP., PapeW., SiegemundB., SpenglerJ., SteilingW., and WiebelF.J. (1991). Interlaboratory assessment of alternatives to the Draize eye irritation test in Germany.Toxicology in Vitro5, 539–542.
52.
SpielmannH., KalweitS., LiebschM., WirnsbergerT., GernerI., Bertram-NeisW., KrauserK., KreilingG., MiltenburgerH., PapeW., and SteilingW. (1993). Validation study of alternatives to the Draize eye irritation test in Germany: cytotoxicity testing and HET-CAM assay with 136 industrial chemicals.Toxicology in Vitro7, 505–510.
53.
Anon. (1992). OECD Guidelines for the Testing of Chemicals, No. 404: Acute dermal irritation/corrosion, 6 pp. Paris, France: OECD.
54.
Anon. (1987). OECD Guidelines for the Testing of Chemicals, No. 405: Acute eye irritation/corrosion, 9 pp. Paris, France: OECD.
55.
BarrattM.D., BasketterD.A., ChamberlainM., AdmansG.D., and LangowskiJ.J. (1994). An expert system rulebase for identifying contact allergens.Toxicology in Vitro8, 1053–1060.
56.
BarrattM.D. (1995). Quantitative structure-activity relationships for skin permeability.Toxicology in Vitro9, 27–37.
57.
HermensJ.L.M. (1989). Quantitative structure-activity relationships of environmental pollutants. In Handbook of Environmental Chemistry, Vol. 2E (ed. HutzingerO.), pp. 111–162. Berlin: Springer-Verlag.
58.
McCartyL.S. (1987). Relationship between toxicity and bioconcentration for some organic chemicals. I. Examination of the relationship. In QSAR in Environmental Toxicology, II (ed. KaiserK.L.E.), pp. 207–220. Dordrecht, The Netherlands: D. Reidel Publishing Company.
59.
McCartyL.S., and MackayD. (1993). Enhancing ecotoxicological modeling and assessment.Environmental Science and Technology27, 1719–1728.
60.
van HoogenG., and OpperhuizenA. (1988). Toxicokinetics of chlorobenzenes in fish.Environmental Toxicology and Chemistry7, 213–219.
61.
VerhaarH.J.M., van LeeuwenC.J., and HermensJ.L.M. (1992). Classifying environmental pollutants. I. Structure-activity relationships for prediction of aquatic toxicity.Chemosphere25, 471–491.
62.
VerhaarH.J.M., van LeeuwenC.J., BolJ., and HermensJ.L.M. (1994). Application of QSARs in risk management of existing chemicals.SAR and QSAR Environmental Research2, 39–58.
63.
WoldS., AlbanoC., DunnW.J.3rd, EdlundU., EsbensenK., GeladiP., HellbergS., JohanssonE., LindbergW., & SjöströmM. (1984). Multivariate data analysis in chemistry. In Chemometrics: Mathematics and Statistics in Chemistry (ed. KowalskiB.R.), pp. 17–95. Dordrecht, The Netherlands: D. Reidel Publishing Company.
64.
CramerC.J., FaminiG.R., and LowreyA.H. (1993). Use of calculated quantum chemical properties as surrogates for solvatochromic parameters in structure-activity relationships.Accounts of Chemical Research26, 599–605.
65.
VerhaarH.J.M. (1995). Predictive Methods in Aquatic Toxicology. PhD Thesis, Utrecht University, The Netherlands.
66.
BothamP.A., ChamberlainM., BarrattM.D., CurrenR.D., EsdaileD.J., GardnerJ.R., GordonV.C., HildebrandB., LewisR.W., LiebschM., LogemannP., OsborneR., PonecM., RégnierJ-F., SteilingW., WalkerA.P., and BallsM. (1995). A prevalidation study on in vitro skin corrosivity testing. The report and recommendations of ECVAM workshop 6.ATLA23, 219–255.
67.
ChamberlainM., and EarlL. (1994). Use of cell cultures in irritancy testing. In Alternative Methods in Toxicology, Volume 10, In Vitro Skin Toxicology: Irritation, Phototoxicity, Sensitisation (ed. RougierA., GoldbergA.M., MaibachH.I.), pp. 59–67. New York, USA: Mary Ann Liebert.
68.
ShivjiG.M., GuptaA.K., and SauderD.N. (1994). Role of cytokines in irritant contact dermatitis. In Alternative Methods in Toxicology, Volume 10, In Vitro Skin Toxicology: Irritation, Phototoxicity, Sensitisation (ed. RougierA., GoldbergA.M., MaibachH.I.), pp. 13–22. New York, USA: Mary Ann Liebert.
69.
AtkinsonK.A., FentemJ.H., ClothierR.H., and BallsM. (1992). Alternatives to ocular irritation testing in animals.Lens and Eye Toxicity Research9, 247–258.
70.
RougierA., CottinM., De SilvaO., CatrouxP., RoguetR., and DossouK.G. (1994). The use of in vitro methods in the ocular irritation assessment of cosmetic products.Toxicology in Vitro8, 893–905.
71.
McCulleyJ.P., and StephensT.J. (1993). Draize eye testing alternatives: a perspective. In Alternative Methods in Toxicology, Volume 9, In Vitro Toxicology: Tenth Anniversary Symposium of CAAT (ed. GoldbergA.M.), pp. 107–119. New York, USA: Mary Ann Liebert.
72.
Anon. (1992). The Use of Animals in Research, Development and Testing, p. 30. London, UK: Parliamentary Office of Science and Technology.
73.
DeldarA., and StevensC.E. (1993). Development and application of in vitro models of hematopoiesis to drug development.Toxicologic Pathology21, 231–240.
74.
ParchmentR.E., HuangM., & Erickson-MillerC.L. (1993). Roles for in vitro myelotoxicity tests in preclinical drug development and clinical trial planning.Toxicologic Pathology21, 241–250.
75.
LakeB.G., LewisD.F.V., GrayT.J.B., and BeamandJ.A. (1993). Structure-activity relationships for induction of peroxisomal enzyme activities in primary rat hepatocyte cultures.Toxicology in Vitro7, 605–614.
76.
TweatsD. (1994). Mutagenicity. In General and Applied Toxicology (ed. BallantyneB., MarrsT., TurnerP.), pp. 871–936. London, UK: Macmillan.
77.
LawletP. (1989). Mutagens as carcinogens: development of current concepts.Mutation Research213, 3–26.
78.
BrusickD. (1994). Genetic toxicology. In Principles and Methods of Toxicology (ed. HayesA.W.), pp. 545–577. New York: Raven Press.
79.
CombesR.D. (1992). Trends in genotoxicity testing.Chemistry in Industry24, 950–954.
80.
AardemaM.J. ed. (1993). Updated worldwide regulatory guidelines for genotoxicity testing. Workshop proceedings from the 1992 Environmental Mutagen Society Meeting.Environmental and Molecular Mutagenesis21, 1–57.
81.
HasemanJ.K., and ClarkA.M. (1990). Carcinogenicity results for 114 laboratory animal studies used to assess the predictivity of four in vitro genetic toxicity assays for rodent carcinogenicity.Environmental and Molecular Mutagenesis16, Suppl. 18, 15–31.
82.
AshbyJ., and TennantR.W. (1988). Chemical structure, Salmonella mutagenicity and extent of carcinogenicity as indicators of genotoxic carcinogenesis among 222 chemicals tested in rodents by the US NCI/NTP.Mutation Research204, 17–115.
83.
AshbyJ., and TennantR.W. (1991). Definitive relationships among chemical structure, carcinogenicity and mutagenicity for 301 chemicals tested by the US NTP.Mutation Research257, 229–306.
84.
AshbyJ., and PatonD. (1993). The influence of chemical structure on the extent and sites of carcinogenesis for 522 rodent carcinogens and 55 different human carcinogen exposures.Mutation Research286, 3–74.
85.
CombesR.D., and JudsonP. (1995). The use of artificial intelligence systems for predicting toxicity.Pesticide Science, in press.
86.
KlopmanG., and RosenkranzH.S. (1994). Approaches to SAR in carcinogenesis and mutagenesis: prediction of carcinogenicity/mutagenicity using MULTI-CASE.Mutation Research305, 33–46.
87.
SandersonD.M., and EarnshawC.G. (1991). Computer prediction of possible toxic action from chemical structure: the DEREK system.Human and Experimental Toxicology10, 261–273.
88.
LongA., and CombesR.D. (1995). Using DEREK to predict the activity of some carcinogens/mutagens found in foods.Toxicology in Vitro, in press.
89.
BenigniR., AndreoliC., and GiulianiA. (1994). QSAR models for both mutagenic potency and activity: application to nitroarenes and aromatic amines.Environmental and Molecular Mutagenesis24, 208–219.
90.
BenigniR., and GiulianiA. (1994). Quantitative modeling and biology: the multivariate approach.American Journal of Physiology266, R1697–1704.
91.
CastellJ.V., & Gómez-LechónM.J. (1992). The in vitro evaluation of the potential risk of hepato-toxicity of drugs. In In Vitro Alternatives to Animal Pharmaco-toxicology (ed. CastellJ.V., & Gómez-LechonM.J.). Madrid, Spain: Farmaindustria.
92.
Gómez-LechónM.J., MontoyaA., LópezP., DonateT., LarrauriA., and CastellJ.V. (1988). The potential use of cultured hepatocytes in predicting the hepatotoxicity of xenobiotics.Xenobiotica18, 725–735.
93.
DonateM.T., CastellJ.V., & Gómez-LechónM.J. (1994). Cytochrome P450 activities in pure and co-cultured rat hepatocytes: effects of model drug inducers.In Vitro Cellular and Developmental Biology30, 825–832.
94.
RuttenA. A.J.J.L., & van de SandtJ.J.M. (1994). In vitro dermal toxicology using skin organ cultures.Toxicology in Vitro8, 703–705.
95.
LeemanW.R., van de GevelI.A., & RuttenA. A.J.J.L. (1995). Cytotoxicity of retinoic acid, menadione and aflatoxin B1 in rat liver slices using Netwell inserts as a new culture system.Toxicology in Vitro9, 291–298.
96.
WolterbeekA.P.M., RoggebandR., SteenwinkelM-J.S.T., BaanR.A., & RuttenA. A.J.J.L. (1993). Formation and repair of benzo[a]pyrene-DNA adducts in cultured hamster tracheal epithelium determined by 32P-postlabelling analysis and unscheduled DNA synthesis.Carcinogenesis14, 463–467.
97.
VedaniA., ZbindenP., and SnyderJ.P. (1993). Pseudo-receptor modeling: a new concept for the three-dimensional construction of receptor binding sites.Journal of Receptor Research13, 163–177.
98.
SnyderJ.P., RaoS.N., KoehlerK.F., and VedaniA. (1993). Pseudoreceptors. In 3D QSAR in Drug Design (ed. KubinyiH.), pp. 336–354. Leiden, The Netherlands: ESCOM Science Publishers.
99.
VedaniA., ZbindenP., SnyderJ.P., and GreenidgeP.A. (1995). Pseudoreceptor modeling: the construction of three-dimensional receptor surrogates.Journal of the American Chemical Society, in press.
100.
RogersD., and HopfingerA.J. (1994). Application of genetic function approximation to quantitative structure-activity relationships and quantitative structure-property relationships.Journal of Chemical Informatics and Computer Science34, 854–866.
101.
ToplissJ.G. (1975). Utilization of operational schemes for analog synthesis in drug design. In Drug Design, Vol. V (ed. AriensE.J.), pp. 1–213New York & London: Academic Press.
102.
HanschC., UngerS.H., and ForsytheA.B. (1973). Strategy in drug design. Cluster analysis as an aid in the selection of substituents.Journal of Medicinal Chemistry16, 1217–1222.
103.
AustellV. (1982). A manual method for systematic drug design.European Journal of Medicinal Chemistry17, 9–16.
104.
StreichW.J., DoveS., and FrankeR. (1980). On the rational selection of test series. I. Principal component method combined with multidimensional mapping.Journal of Medicinal Chemistry23, 1452–1456.
105.
BaroniM., ClementiS., CrucianiG., Kettaneh-WoldN., and WoldS. (1993). D-Optimal designs in QSAR.Quantitative Structure-Activity Relationships12, 225–231.
106.
PleissM.A., and UngerS.H. (1990). The design of test series and the significance of QSAR relationships. In Quantitative Drug Design (ed. RamsdenC.A.), pp. 561–587. Oxford, UK: Pergamon Press.